A8501 (2023-24 session)
NY State bill
Requires written notice of an adverse determination made by a utilization review agent in relation to a step therapy protocol override determination which includes the clinical review criteria relied upon to make such determination and any applicable alternative prescription drugs subject to the step therapy protocol of the utilization review agent.
- Title
- Relates to adverse determinations related to a step therapy protocol override determination; repealer
- Type
- New York State Assembly bill
- Session
- 2023-24 session
- Status
- Signed by Governor
- Latest action date
- 2024-02-07
- Introduced
- 2024-01-04
- Same as
- S8038
- Law section
- Insurance Law
Sponsors
Heard in committee
Same as
- S8038 (2023-24 session) NY State bill
Substituted for
- S8038 (2023-24 session) NY State bill